Continuous Foot ECG & Peripheral Circulation Track
FDA Regulatory Pathway Paragraph
Our Commitment to Regulations
At RDL Ventures, clinical accuracy and patient safety are at the core of our engineering philosophy. Our foot-worn ECG and peripheral tracking hardware is actively being developed to align with the FDA’s stringent requirements for Class II digital health technology. We are pursuing the established FDA 510(k) Premarket Notification clearance pathway, demonstrating substantial equivalence to existing medical-grade cardiac and non-invasive physiologic tracking devices. By rigorously following the FDA's latest digital health software guidelines and establishing a HIPAA-compliant data architecture, we ensure that the metrics delivered to lower-limb specialists are trustworthy, secure, and ready for immediate clinical review.